{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:39:41Z","timestamp":1792629581026,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,7,15]],"date-time":"2015-07-15T00:00:00Z","timestamp":1436918400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s40261-015-0306-6","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T12:35:12Z","timestamp":1436877312000},"page":"505-512","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intravesical Glycosaminoglycan Replacement with Chondroitin Sulphate (Gepan\u00ae instill) in Patients with Chronic Radiotherapy- or Chemotherapy-Associated Cystitis"],"prefix":"10.1007","volume":"35","author":[{"given":"Thilo","family":"Schwalenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank Peter","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Christian","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuc Ho","family":"Thi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens\u2010Uwe","family":"Stolzenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,15]]},"reference":[{"issue":"6","key":"306_CR1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00192-010-1357-0","volume":"22","author":"MH Hazewinkel","year":"2011","unstructured":"Hazewinkel MH, Stalpers LJ, Dijkgraaf MG, Roovers JP. Prophylactic vesical instillations with 0.2\u00a0% chondroitin sulfate may reduce symptoms of acute radiation cystitis in patients undergoing radiotherapy for gynecological malignancies. Int Urogynecol J. 2011;22(6):725\u201330.","journal-title":"Int Urogynecol J"},{"issue":"3","key":"306_CR2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/sj.bjc.6602301","volume":"92","author":"DP Dearnaley","year":"2005","unstructured":"Dearnaley DP, Hall E, Lawrence D, Huddart RA, Eeles R, Nutting CM, Gadd J, Warrington A, Bidmead M, Horwich A. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer. 2005;92(3):488\u201398.","journal-title":"Br J Cancer"},{"issue":"1","key":"306_CR3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1525-1438.2006.00373.x","volume":"16","author":"TP Shakespeare","year":"2006","unstructured":"Shakespeare TP, Lim KH, Lee KM, Back MF, Mukherjee R, Lu JD. Phase II study of the American Brachytherapy Society guidelines for the use of high-dose rate brachytherapy in the treatment of cervical carcinoma: is 45\u201350.4\u00a0Gy radiochemotherapy plus 31.8\u00a0Gy in six fractions high-dose rate brachytherapy tolerable? Int J Gynecol Cancer. 2006;16(1):277\u201382.","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"306_CR4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.acuro.2010.03.005","volume":"34","author":"R Martinez-Rodriguez","year":"2010","unstructured":"Mart\u00ednez-Rodr\u00edguez R, Areal Calama J, Buisan Rueda O, Gonz\u00e1lez Satue C, Sanchez Macias J, Arzoz Fabregas M, Gago Ramos J, Bayona Arenas S, Ibarz Servio L, Saladi\u00e9 Roig JM. Practical treatment approach of radiation induced cystitis. Actas Urol Esp. 2010;34(7):603\u20139 (in Spanish).","journal-title":"Actas Urol Esp"},{"issue":"4","key":"306_CR5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1464-410X.2003.04655.x","volume":"93","author":"MD Shelley","year":"2004","unstructured":"Shelley MD, Wilt TJ, Court J, Coles B, Kynaston H, Mason MD. Intravesical bacillus Calmette-Guerin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials. BJU Int. 2004;93(4):485\u201390.","journal-title":"BJU Int"},{"issue":"4","key":"306_CR6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrurol.2010.23","volume":"7","author":"SG Smit","year":"2010","unstructured":"Smit SG, Heyns CF. Management of radiation cystitis. Nat Rev Urol. 2010;7(4):206\u201314.","journal-title":"Nat Rev Urol"},{"issue":"4","key":"306_CR7","first-page":"381","volume":"82","author":"FJ Berkey","year":"2010","unstructured":"Berkey FJ. Managing the adverse effects of radiation therapy. Am Fam Physician. 2010;82(4):381\u20138 (394).","journal-title":"Am Fam Physician."},{"issue":"1","key":"306_CR8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/2051415813512647","volume":"7","author":"A Thompson","year":"2014","unstructured":"Thompson A, Adamson A, Bahl A, Borwell J, Dodds D, Heath C, Huddart R, McMenemin R, Patel P, Peters J, et al. Guidelines for the diagnosis, prevention and management of chemical- and radiation-induced cystitis. J Clin Urol. 2014;7(1):25\u201335.","journal-title":"J Clin Urol"},{"issue":"1","key":"306_CR9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/nau.22256","volume":"32","author":"H Madersbacher","year":"2013","unstructured":"Madersbacher H, van Ophoven A, van Kerrebroeck PE. GAG layer replenishment therapy for chronic forms of cystitis with intravesical glycosaminoglycans\u2014a review. Neurourol Urodyn. 2013;32(1):9\u201318.","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"306_CR10","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00120-013-3130-8","volume":"52","author":"D Jocham","year":"2013","unstructured":"Jocham D, Froehlich G, Sandig F, Ziegler A. The care situation of patients with interstitial cystitis in Germany: results of a survey of 270 patients. Urologe A. 2013;52(5):691\u2013702 (in German).","journal-title":"Urologe A"},{"issue":"12","key":"306_CR11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrurol.2012.217","volume":"9","author":"J Neuhaus","year":"2012","unstructured":"Neuhaus J, Schwalenberg T. Intravesical treatments of bladder pain syndrome\/interstitial cystitis. Nat Rev Urol. 2012;9(12):707\u201320.","journal-title":"Nat Rev Urol"},{"issue":"2","key":"306_CR12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.urology.2011.10.010","volume":"79","author":"CD Engles","year":"2012","unstructured":"Engles CD, Hauser PJ, Abdullah SN, Culkin DJ, Hurst RE. Intravesical chondroitin sulfate inhibits recruitment of inflammatory cells in an acute acid damage \u201cleaky bladder\u201d model of cystitis. Urology. 2012;79(2):483 (e413\u2013487).","journal-title":"Urology"},{"issue":"7","key":"306_CR13","first-page":"328","volume":"58","author":"J Nordling","year":"2008","unstructured":"Nordling J, van Ophoven A. Intravesical glycosaminoglycan replenishment with chondroitin sulphate in chronic forms of cystitis: a multi-national, multi-centre, prospective observational clinical trial. Arzneimittelforschung. 2008;58(7):328\u201335.","journal-title":"Arzneimittelforschung"},{"issue":"5","key":"306_CR14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1756287211418723","volume":"3","author":"R Damiano","year":"2011","unstructured":"Damiano R, Cicione A. The role of sodium hyaluronate and sodium chondroitin sulphate in the management of bladder disease. Ther Adv Urol. 2011;3(5):223\u201332.","journal-title":"Ther Adv Urol"},{"issue":"2","key":"306_CR15","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.juro.2007.09.022","volume":"179","author":"PJ Hauser","year":"2008","unstructured":"Hauser PJ, Dozmorov MG, Bane BL, Slobodov G, Culkin DJ, Hurst RE. Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis. J Urol. 2008;179(2):764\u20139.","journal-title":"J Urol"},{"issue":"3","key":"306_CR16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1464-410X.2010.09843.x","volume":"107","author":"CL Parsons","year":"2011","unstructured":"Parsons CL. The role of a leaky epithelium and potassium in the generation of bladder symptoms in interstitial cystitis\/overactive bladder, urethral syndrome, prostatitis and gynaecological chronic pelvic pain. BJU Int. 2011;107(3):370\u20135.","journal-title":"BJU Int"},{"issue":"9","key":"306_CR17","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00120-007-1480-9","volume":"46","author":"J Neuhaus","year":"2007","unstructured":"Neuhaus J, Heinrich M, Schlichting N, Oberbach A, Fitzl G, Schwalenberg T, Horn LC, Stolzenburg JU. Structure and function of suburothelial myofibroblasts in the human urinary bladder under normal and pathological conditions (in German). Urologe A. 2007;46(9):1197\u2013202.","journal-title":"Urologe A"},{"issue":"2","key":"306_CR18","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1128\/IAI.24.2.552-557.1979","volume":"24","author":"CL Parsons","year":"1979","unstructured":"Parsons CL, Mulholland SG, Anwar H. Antibacterial activity of bladder surface mucin duplicated by exogenous glycosaminoglycan (heparin). Infect Immun. 1979;24(2):552\u20137.","journal-title":"Infect Immun"},{"issue":"1","key":"306_CR19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.juro.2012.09.022","volume":"189","author":"DA Janssen","year":"2013","unstructured":"Janssen DA, van Wijk XM, Jansen KC, van Kuppevelt TH, Heesakkers JP, Schalken JA. The distribution and function of chondroitin sulfate and other sulfated glycosaminoglycans in the human bladder and their contribution to the protective bladder barrier. J Urol. 2013;189(1):336\u201342.","journal-title":"J Urol"},{"issue":"5","key":"306_CR20","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.juro.2009.07.013","volume":"182","author":"PJ Hauser","year":"2009","unstructured":"Hauser PJ, Buethe DA, Califano J, Sofinowski TM, Culkin DJ, Hurst RE. Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate. J Urol. 2009;182(5):2477\u201382.","journal-title":"J Urol"},{"key":"306_CR21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2490-5-4","volume":"5","author":"KD Kyker","year":"2005","unstructured":"Kyker KD, Coffman J, Hurst RE. Exogenous glycosaminoglycans coat damaged bladder surfaces in experimentally damaged mouse bladder. BMC Urol. 2005;5:4.","journal-title":"BMC Urol"},{"issue":"6","key":"306_CR22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1055\/s-0029-1224600","volume":"40","author":"A Gauruder-Burmester","year":"2009","unstructured":"Gauruder-Burmester A, Popken G. Follow-up at 24\u00a0months after treatment of overactive bladder with 0.2\u00a0% sodium chondroitin sulfate. Aktuelle Urol. 2009;40(6):355\u20139 (in German).","journal-title":"Aktuelle Urol"},{"issue":"7","key":"306_CR23","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/cncr.25467","volume":"117","author":"ZA Alicikus","year":"2011","unstructured":"Alicikus ZA, Yamada Y, Zhang Z, Pei X, Hunt M, Kollmeier M, Cox B, Zelefsky MJ. Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer. Cancer. 2011;117(7):1429\u201337.","journal-title":"Cancer"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-015-0306-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-015-0306-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-015-0306-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:34:56Z","timestamp":1599266096000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-015-0306-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,15]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["306"],"URL":"https:\/\/doi.org\/10.1007\/s40261-015-0306-6","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,15]]}}}